Islet-reactive CD8+ T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors.
Saved in:
| Title: | Islet-reactive CD8+ T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors. |
|---|---|
| Authors: | Culina S; INSERM, U1016, Cochin Institute, Paris, France.; CNRS, UMR8104, Cochin Institute, Paris, France.; Paris Descartes University, Sorbonne Paris Cité, Paris, France., Lalanne AI; INSERM, U1016, Cochin Institute, Paris, France.; CNRS, UMR8104, Cochin Institute, Paris, France.; Paris Descartes University, Sorbonne Paris Cité, Paris, France., Afonso G; INSERM, U1016, Cochin Institute, Paris, France.; CNRS, UMR8104, Cochin Institute, Paris, France.; Paris Descartes University, Sorbonne Paris Cité, Paris, France., Cerosaletti K; Benaroya Research Institute, Translational Research Program, Seattle, WA 98101, USA., Pinto S; Division of Developmental Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Sebastiani G; Diabetes Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, and Fondazione Umberto di Mario ONLUS, Toscana Life Sciences, Siena, Italy., Kuranda K; INSERM, U1016, Cochin Institute, Paris, France.; CNRS, UMR8104, Cochin Institute, Paris, France.; Paris Descartes University, Sorbonne Paris Cité, Paris, France., Nigi L; Diabetes Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, and Fondazione Umberto di Mario ONLUS, Toscana Life Sciences, Siena, Italy., Eugster A; CRTD-DFG Research Center for Regenerative Therapies Dresden, Medical Faculty, Technische Universität Dresden, Dresden, Germany., Østerbye T; Department of International Health, Immunology and Microbiology, Panum Institute, Copenhagen, Denmark., Maugein A; INSERM, U1016, Cochin Institute, Paris, France.; CNRS, UMR8104, Cochin Institute, Paris, France.; Paris Descartes University, Sorbonne Paris Cité, Paris, France., McLaren JE; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK., Ladell K; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK., Larger E; INSERM, U1016, Cochin Institute, Paris, France.; CNRS, UMR8104, Cochin Institute, Paris, France.; Paris Descartes University, Sorbonne Paris Cité, Paris, France.; Assistance Publique Hôpitaux de Paris, Service de Diabétologie, Cochin Hospital, Paris, France., Beressi JP; Centre Hospitalier de Versailles André Mignot, Service de Diabétologie, Le Chesnay, France., Lissina A; Pierre et Marie Curie Paris 6 University, Sorbonne Paris Cité, Département Hospitalo-Universitaire FAST, CR7, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.; INSERM, U1135, CIMI-Paris, Paris, France., Appay V; Pierre et Marie Curie Paris 6 University, Sorbonne Paris Cité, Département Hospitalo-Universitaire FAST, CR7, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.; INSERM, U1135, CIMI-Paris, Paris, France., Davidson HW; Barbara Davis Center for Diabetes and Integrated Department of Immunology, University of Colorado Denver Anschutz Medical Campus, Aurora, CO 80045, USA., Buus S; Department of International Health, Immunology and Microbiology, Panum Institute, Copenhagen, Denmark., Price DA; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Kuhn M; Institut für Medizinische Informatik und Biometrie, Medical Faculty, Technische Universität Dresden, Dresden, Germany., Bonifacio E; CRTD-DFG Research Center for Regenerative Therapies Dresden, Medical Faculty, Technische Universität Dresden, Dresden, Germany., Battaglia M; Diabetes Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy., Caillat-Zucman S; Assistance Publique Hôpitaux de Paris, Laboratoire d'Immunologie et Histocompatibilité, Hôpital Saint-Louis, Paris, France., Dotta F; Diabetes Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, and Fondazione Umberto di Mario ONLUS, Toscana Life Sciences, Siena, Italy., Scharfmann R; INSERM, U1016, Cochin Institute, Paris, France.; CNRS, UMR8104, Cochin Institute, Paris, France.; Paris Descartes University, Sorbonne Paris Cité, Paris, France., Kyewski B; Division of Developmental Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Mallone R; INSERM, U1016, Cochin Institute, Paris, France. roberto.mallone@inserm.fr.; CNRS, UMR8104, Cochin Institute, Paris, France.; Paris Descartes University, Sorbonne Paris Cité, Paris, France.; Assistance Publique Hôpitaux de Paris, Service de Diabétologie, Cochin Hospital, Paris, France. |
| Corporate Authors: | ImMaDiab Study Group |
| Source: | Science immunology [Sci Immunol] 2018 Feb 02; Vol. 3 (20). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101688624 Publication Model: Print Cited Medium: Internet ISSN: 2470-9468 (Electronic) Linking ISSN: 24709468 NLM ISO Abbreviation: Sci Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
